Anti-cancer medicaments

Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S330000, C544S331000, C544S122000

Reexamination Certificate

active

10746607

ABSTRACT:
Novel compounds and methods of using those compounds for the treatment of oncological conditions are provided. In a preferred embodiment, modulation of the activation states of abl or bcr-abl α-kinase proteins comprises the step of contacting the kinase proteins with the novel compounds.

REFERENCES:
patent: 4296237 (1981-10-01), Cragoe, Jr.
patent: 4366189 (1982-12-01), Burdeska et al.
patent: 4432992 (1984-02-01), Cragoe, Jr. et al.
patent: 5103014 (1992-04-01), Musser et al.
patent: 5494925 (1996-02-01), Court et al.
patent: 6020357 (2000-02-01), Pinto et al.
patent: 6166219 (2000-12-01), Yamasaki et al.
patent: 6235786 (2001-05-01), Dai et al.
patent: 6294573 (2001-09-01), Curtin et al.
patent: 6319921 (2001-11-01), Cirillo et al.
patent: 6352985 (2002-03-01), Yamasaki et al.
patent: 2001/0008898 (2001-07-01), Tomiyama et al.
patent: 2003/0181411 (2003-09-01), Bosch et al.
patent: 2003/0186221 (2003-10-01), Lockhart et al.
patent: 2005/0288286 (2005-12-01), Flynn et al.
patent: 2134915 (1993-11-01), None
patent: 2 156 343 (1972-05-01), None
patent: 2 341 064 (1974-03-01), None
patent: 4302702 (1994-08-01), None
patent: 4337847 (1995-05-01), None
patent: 4343831 (1995-06-01), None
patent: 44 14 840 (1995-11-01), None
patent: 4414840 (1995-11-01), None
patent: 0021228 (1981-01-01), None
patent: 0025232 (1981-03-01), None
patent: 0739884 (1996-10-01), None
patent: 0867435 (1998-09-01), None
patent: 0927555 (1999-07-01), None
patent: 0956855 (1999-11-01), None
patent: 1281399 (2003-02-01), None
patent: 2 337 554 (1977-08-01), None
patent: 2 396 549 (1979-02-01), None
patent: 971307 (1964-09-01), None
patent: 1127875 (1967-03-01), None
patent: 2276161 (1984-09-01), None
patent: 2220206 (1990-01-01), None
patent: 59-15247 (1984-01-01), None
patent: 59-177557 (1984-10-01), None
patent: 9-221476 (1997-08-01), None
patent: 10-7804 (1998-01-01), None
patent: 11-209350 (1999-08-01), None
patent: 2000-275886 (2000-10-01), None
patent: 2001-2687 (2001-01-01), None
patent: WO9119708 (1991-12-01), None
patent: WO9208693 (1992-05-01), None
patent: WO9424095 (1994-10-01), None
patent: WO9515954 (1995-06-01), None
patent: WO9534540 (1995-12-01), None
patent: WO9616046 (1996-05-01), None
patent: WO9619477 (1996-06-01), None
patent: WO9734900 (1997-09-01), None
patent: WO9822103 (1998-05-01), None
patent: WO9915164 (1999-04-01), None
patent: WO9923093 (1999-05-01), None
patent: WO9959959 (1999-11-01), None
patent: WO0002851 (2000-01-01), None
patent: WO0007980 (2000-02-01), None
patent: WO0018738 (2000-04-01), None
patent: WO0021927 (2000-04-01), None
patent: WO0041698 (2000-07-01), None
patent: WO0043384 (2000-07-01), None
patent: WO0059506 (2000-10-01), None
patent: WO0112621 (2001-02-01), None
patent: WO0114372 (2001-03-01), None
patent: WO0174771 (2001-10-01), None
patent: WO0196298 (2001-12-01), None
patent: WO0214291 (2002-02-01), None
patent: WO0228835 (2002-04-01), None
patent: WO0234727 (2002-05-01), None
patent: WO0240458 (2002-05-01), None
patent: WO02060869 (2002-08-01), None
patent: WO02060876 (2002-08-01), None
patent: WO03000189 (2003-01-01), None
patent: WO03053368 (2003-07-01), None
patent: WO03059373 (2003-07-01), None
patent: WO03072577 (2003-09-01), None
O'Dell, J., et al. “Treatment of Rheumatoid Arthritis with Methotrexate Alone, Sulfasalazine and Hydroxychloroquine, or a Combination of All Three Medications,” New. Eng. J. Med., vol. 334(20), pp. 1287-1291 (May 1996), at p. 1287, col. 1, lines 6-9.
Dumas, “Protein Kinase Inhibitors: Emerging From a Pharmacophores 1997-2000”, Expert Opinion on Therepeudic Patents, (2001), vol. 11, pp. 405-429.
Schindler et al., “Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase”, Science, (Sep. 15, 2000), vol. 289, pp. 1938-1942.
Pargellis et al., “Inhibition of P38 MAp Kinase by Utilizing a Novel Allosteric Binding Site”, Nature Structural Biology, (Apr. 2002), vol. 9, pp. 268-272.
Nofal et al., “Synthesis of Novel Uracil-5-Sulphonamide Derivatives of Possible Biological Activity”, Egypt Journal of Chemistry, (1990), vol. 33, pp. 375-380.
Johnson et al., “The Stereochemistry Oxidation at Sulfur”, Tetrahedron, (1969), vol. 25, pp. 5649-5653.
Griffith et al., “TPAP: Tetra-In-Propylammonium Perruthenate, a Mild and Convenient Oxidant for Alcohols”, Aldrichimica Acta, (1990), vol. 23, pp. 13-19.
Zvilichovsky et al., “Aminolysis and Polymerization 3-(p-toluenesulfonoxy) Hydantoin”, Israel Journal of Chemistry, (1969), vol. 7, pp. 547-554.
Yang et al., “Palladimum-Catalyzed Amination of Aryl Halides and Sulfonates”, Journal of Organlmetallic Chemistry, (1999), vol. 576, pp. 125-146.
Kwong et al., “A General, Efficient, an Inexpensive Catalyst System for the Coupling of Aryl Iodies and Thiols”, Organic Letters, (2002), vol. 4, pp. 3517-3520.
Leca et al., “A New Practical 1-Pot Access to Sulfonimidates”, Organic Letters, (2002), vol. 4, pp. 4093-4095.
Cheng et al., “Novel Solution Phase Strategy for the Synthesis of Chemical Libraries Containing Small Organic Molecules”, Journal American Chemical Society, (1996), vol. 118, pp. 2567-2573.
Dess et al., “A Useful 12-I-5 Triacetoxyperiodinane (the Dess-Martin Periodinane) for the Selective Oxidation of Primary or Secondary Alcohols in a Variety of Related 12-I-5 Species”, Journal American Chemical Society , (1991), vol. 113, pp. 7277-7287.
Bausch et al., “Proton-transfer Chemistry of Urazoles and Related Imides, Amides and Diacyl Hydrazides”, Journal Organic Chemistry, (1991), vol. 56, pp. 5643-5651.
Muller et al., “A General Synthesis of 4-substituted 1, 1-Dioxo-1, 2, 5-thiadiazolidin-3-ones Derived From a-Amino Acids”, The Journal of Organic Chemistry, (1989), vol. 54, pp. 4471-4473.
Klyman et al., “The Reaction of S-Methiodide Derivatives of Activated Thioureas with Hydroxylic Compounds. A Novel Synthesis of Mercaptans”, Journal of Organic Chemistry, (1972), vol. 37, pp. 1532-1537S.
Tremblay et al., “Efficient Solid-Phase Synthesis of Sulfahydantoins”, Journal of Combinatorial Chemistry, (2002), vol. 4, pp. 429-435.
Peng et al., “Identification of Novel Inhibitors of BCR-ABL Tyrosine Kinase via Virtual Screening”, Journal of Bioorganic and Medicinal Chemistry Letters, (2003), vol. 13, pp. 3693-3699.
Huse et al., “Conformational Plasticity of Protein Kinases”, Cell, (2002), vol. 109, pp. 275-282.
Teague, “Implications of Protein Flexibility for Drug Discovery”, Nature Reviews, (Jul. 2003), vol. 2, pp. 527-541.
Wu et al., “Discovery of a Novel Family of CDK Inhibitors with the Program LIDAEUS: Structural Basis for Ligand-Induced Disordering of the Activation Loop”, Structure, (2003), vol. 11, pp. 399-410.
Askew et al., “Molecular Recognition with Convergent Functions Groups. Synthetic Instructural Studies with a Model Receptor for Nucleic Acid Components”, Journal of American Chemical Society, (1989), vol. 111, pp. 1082-1090.
Regan et al., “Pyrazole Urea-Based Inhibitors of p38MAP Kinase: From Lead Compound to Clinical Candidate”, Journal of Medicinal Chemistry, (2002), vol. 45, pp. 2994-3008.
Venter, et al., “The Sequence of the Human Genome”, Science, (2001), vol. 291, pp. 1304-1351.
“Initial Sequencing and Analysis of the Human Genome”, Nature, (2001), vol. 409, pp. 860-921.
Wollter et al., “Copper-Catalyzed Coupling of Aryl Iodides with Aliphatic Alcohols”, Organic Letters, (2002), vol. 4, pp. 973-976.
Martinez et al., “First Non-ATP Competitive Glycogen Synthase Kinase 3β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease”, Journal of Medicinal Chemistry , (2002), vol. 45, pp. 1292-1299.
Almerico et al., “On the Preparation of 1-Aryl-2-Heteroaryl- and 2-Aryl-1-Heteroaryl-Pyrroles as Useful Building Blocks for Biologically

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Anti-cancer medicaments does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-cancer medicaments, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-cancer medicaments will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3823425

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.